Share This Author
Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles.
Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study.
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
- W. Kruis, S. Chrubasik, S. Boehm, C. Stange, J. Schulze
- MedicineInternational Journal of Colorectal Disease
- 2 December 2011
Probiotic EcN shows effects in irritable bowel syndrome, especially in patients with altered enteric microflora, e.g. after gastroenterocolitis or administration of antibiotics.
Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.
A systematic review on the sambuci fructus effect and efficacy profiles
A comprehensive review of the literature was conducted to summarize the pharmacological and clinical effects of elderberry fruit.
Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations.
A systematic review on the Rosa canina effect and efficacy profiles
- C. Chrubasik, B. Roufogalis, U. Müller-Ladner, S. Chrubasik
- MedicinePhytotherapy research : PTR
- 1 December 2007
A comprehensive review of the literature was conducted to summarize the pharmacological and clinical effects of Rosa canina L. to reevaluate its usefulness in traditional medicine.
Oral herbal therapies for treating osteoarthritis.
The quality of the body of evidence was assessed using the GRADE approach for major outcomes and it was uncertain if a 99 mg daily dose of Boswellia serrata offered benefits over valdecoxib due to the very low-quality evidence from a small single study.
A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix.
Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review
- J. Gagnier, S. Chrubasik, E. Manheimer
- MedicineBMC complementary and alternative medicine
- 15 September 2004
There is limited evidence for an ethanolic Harpagophytum extract containing less than <30 mg harpagoside per day in the treatment of knee and hip osteoarthritis, and strong evidence exists for the use of an aqueous HarPagophyTum extract at a daily dose equivalent of 50 mg harPagoside in the Treatment of acute exacerbations of chronic NSLBP.